Concepedia

Miao Xu

MX

46

Publications

5.6K

Citations

26

H-Index

2010

Active since

Affiliations

National Institutes for Food and Drug Control(Current)

Chinese Academy of Medical Sciences & Peking Union Medical College

National Center for Advancing Translational Sciences

Sinovac Biotech

National Vaccine and Serum Institute

Miao Xu is an author at National Institutes for Food and Drug Control specializing in medicine, immunology, and vaccination.

ORCID

Top concepts

Publications per year

2010–2024

46

Publications

46

Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial

Shengli Xia, Yuntao Zhang, Yanxia Wang et al. · The Lancet Infectious Diseases · 2020 · 1.2K citations · Full text

, , +5

Development of an Inactivated Vaccine Candidate, BBIBP-CorV, with Potent Protection against SARS-CoV-2

Hui Wang, Yuntao Zhang, Baoying Huang et al. · Cell · 2020 · 796 citations · Full text

, , +7

Establishment and validation of a pseudovirus neutralization assay for SARS-CoV-2

Jianhui Nie, Qianqian Li, Jiajing Wu et al. · Emerging Microbes & Infections · 2020 · 793 citations · Full text

, , +13

Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy adults aged 60 years and older: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial

Zhiwei Wu, Yaling Hu, Miao Xu et al. · The Lancet Infectious Diseases · 2021 · 572 citations · Full text

Quantification of SARS-CoV-2 neutralizing antibody by a pseudotyped virus-based assay

Jianhui Nie, Qianqian Li, Jiajing Wu et al. · Nature Protocols · 2020 · 460 citations · Full text

, , +7

Rows per page

1–5 of 46